Potential of transglutaminase 2 as a therapeutic target

Author： Caccamo Daniela Currò Monica Ientile Riccardo

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.9, 2010-09, pp. : 989-1003

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 3, 2010-09 ,pp. : 224-234

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroinflammation: a potential therapeutic target

By Craft Jeffrey M Watterson D Martin Van Eldik Linda J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 887-900

Informa Healthcare

Access to resources Recommend Favorite

New Therapeutic Strategies for Coeliac Disease: Tissue Transglutaminase as a Target

Current Medicinal Chemistry, Vol. 14, Iss. 24, 2007-10 ,pp. : 2572-2580

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenase-2 Pathway as a Potential Therapeutic Target in Diabetic Peripheral Neuropathy

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 68-76

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Serine Protease HtrA2/Omi as a Potential Therapeutic Target

Current Drug Targets, Vol. 10, Iss. 4, 2009-04 ,pp. : 372-383

Bentham Science Publishers

Access to resources Recommend Favorite